Engineered nanoparticles can improve cancer immunotherapy by delivering drugs, antigens, and genetic payloads with greater ...

Across the immunity cycle, NPs can co-deliver tumor antigens and adjuvants to DCs, enhance major histocompatibility complex class I (MHC-I)-mediated cross-presentation, and promote cytotoxic T ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.

Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...

This schematic illustrates stratification of gastrointestinal tract cancers based on their sensitivity to immunotherapy, thereby dictating distinct therapeutic paradigms that guide clinical ...

Findings showed Orca-T statistically significantly improved survival free of moderate to severe cGvHD vs alloHSCT at 1 year. The Food and Drug Administration (FDA) has accepted for Priority Review the ...

Generally, the standard treatment for solid tumors is surgery. However, a recent study from New York City-based Memorial Sloan Kettering Cancer Center found immunotherapy can effectively treat these ...

Cedars-Sinai used a nursing education framework to shift a 63-bed oncology unit to a progressive care model, improving ...